Dissertation/Thesis Abstract

Role of Hindbrain Adenosine 5'-Monophosphate Activated Protein Kinase (AMPK) in Hypothalmic AMPK and Metabolic Neuropeptides Response to Acute and Recurring Insulin Induced Hypoglycemia
by Mandal, Santosh, Ph.D., University of Louisiana at Monroe, 2019, 200; 22582889
Abstract (Summary)

Hypoglycemia poses a significant threat to neurological function as neurons require a continuous glucose supply to sustain vital high-energy functions but have access to limited fuel reserves. Neuroglycopenia triggers an integrated array of counter-regulatory autonomic, neuroendocrine, and behavioral responses that enhance systemic glucose availability. Conventional therapeutic strategies involving treatment with intermediate-release insulin formulations for mandatory strict glycemic control in type I diabetes mellitus regularly produce iatrogenic hypoglycemia. In diabetic patients, antecedent hypoglycemia is a primary cause of hypoglycemia-associated autonomic failure (HAAF), which exacerbates the risk of neurological dysfunction and injury due to diminished hypoglycemic awareness and suppressed counter-regulatory outflow.

Glucose counter-regulatory collapse correlates with impaired activation of the hypothalamic metabolic sensor adenosine 5′monophosphate-activated protein kinase (AMPK). Hindbrain energy status controls hypothalamic AMPK. Results show that recurrent insulin-induced hypoglycemia (RIIH) elicited compound C-reversible augmentation of ventromedial hypothalamic nucleus (VMN) glutamate decarboxylase, arcuate pro-opiomelanocortin, and lateral hypothalamic orexin-A proteins or reductions

in VMH nitric oxide synthase profiles but caused adaptation of other hypothalamic metabolic neurotransmitter proteins without hindbrain sensor involvement. Data also show acclimated up-regulation of total AMPK protein expression in multiple hypothalamic loci during RIIH, and document hindbrain sensor contribution to upregulation of AMPK in ARH, VMH. Hindbrain AMPK required for acute hypoglycemic intensification of norepinephrine (NE) activity in characterized hypothalamic gluco-regulatory structures. Outcomes here indicate that hindbrain lactoprivic-driven NE signaling to those hypothalamic loci may acclimate to RIIH because of lessened A2 neuron reactivity to hypoglycemia-related decrements in this oxidizable glycolytic-derived energy fuel. Lastly, VMN metabolic-sensory nitrergic neurons exhibit significantly up-regulated expression of characterized biomarkers for pyruvate recycling pathway activity, e.g., glutaminase and malic enzyme-1, alongside diminished AMPK activation and altered patterns of adrenergic receptor expression. These findings show that habituated receptor-specific sensitivity of VMN sensing neurons to NE may correlate with augmented utilization of amino acids as a non-glucose energy substrate and decreased the reactivity of these cells to hypoglycemia.

Supplemental Files

Some files may require a special program or browser plug-in. More Information

Indexing (document details)
Advisor: Briski, Karen P.
Commitee: Sylvester, Paul W., Liu, Yong Yu, Jackson, Keith E.
School: University of Louisiana at Monroe
Department: Pharmacy
School Location: United States -- Louisiana
Source: DAI-B 81/2(E), Dissertation Abstracts International
Source Type: DISSERTATION
Subjects: Nanoscience, Pharmaceutical sciences
Keywords: Hypoglycemia, Neuroglycopenia, AMPK
Publication Number: 22582889
ISBN: 9781085647687
Copyright © 2019 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest